Sign in
Surgical Implantation of a Biosynthetic RPE Monolayer for Advanced Dry Age-Related Macular Degeneration (AMD): Experience From a Phase 1/2A Study
Amir H Kashani, MD PhD
Annual Meeting Talks
2019
Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
2022
Therapeutic Horizons for Dry AMD
Robert L. Avery, MD
Updates from the Field
Category: AMD-Non-Neovascular